23andme Holding CO Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

23andMe Holding Co., currently undergoing Chapter 11 bankruptcy, has agreed to sell substantially all of its assets, including its genetic testing and Lemonaid businesses, to TTAM Research Institute, an affiliate of CEO Anne Wojcicki, for $302.5 million, pending Bankruptcy Court approval.
Activist investors Zentree Investments Limited and Richard Magides have disclosed an 18.2% beneficial ownership in 23andMe Holding Co., advocating for minority shareholder rights, prudent cost management, and equal treatment for Class A and Class B shares.
Zentree Investments Limited and Richard Magides have disclosed a 16.0% beneficial ownership stake in 23andMe Holding Co., signaling an activist intent to advocate for minority shareholder rights, improved cost management, and equal share class rights.
Activist investors Richard Magides and Zentree Investments Limited have disclosed a 13.0% beneficial ownership stake in 23andMe Holding Co., signaling an intent to advocate for minority shareholder rights, prudent cost management, and equal voting rights for all share classes.
Anne Wojcicki, CEO of 23andMe Holding Co., has submitted an updated proposal to acquire all outstanding shares not owned by her and affiliates, maintaining the total consideration of up to $2.94 per share while offering new financing and committing to significant operating expense reductions to avoid bankruptcy.
23andMe Holding Co-founder Anne Wojcicki has submitted a revised non-binding proposal to acquire all outstanding shares not owned by her and affiliates for up to $2.94 per share, including upfront cash and contingent value rights, aiming to take the company private to avoid bankruptcy.
23andMe Holding Co. founder Anne Wojcicki has submitted a non-binding proposal to acquire all outstanding shares not already owned by her and affiliates for $0.41 per share in cash, aiming to take the company private.
23andMe Holding Co. has received a non-binding proposal from co-founder Anne Wojcicki and New Mountain Capital L.L.C. to acquire all outstanding shares not already owned by Ms. Wojcicki and her affiliates for $2.53 per share in cash.
23andMe Holding Co. CEO Anne Wojcicki has reversed her previous position, indicating a willingness to consider third-party takeover proposals or other strategic alternatives for the company.